Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
Alexandru A. Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 4, pp. e1009064-e1009064
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
Hasnat Tariq, Sannia Batool, Saaim Asif, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 144
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
Cell Reports (2021) Vol. 36, Iss. 4, pp. 109452-109452
Open Access | Times Cited: 119
Status Report on COVID-19 Vaccines Development
Arun Kumar, William E. Dowling, Raúl Gómez Román, et al.
Current Infectious Disease Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 78
Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
Rüdiger Groß, Hanna Reßin, Pascal von Maltitz, et al.
Nature Microbiology (2024) Vol. 9, Iss. 4, pp. 905-921
Open Access | Times Cited: 11
COVID-19 Vaccines: Where Did We Stand at the End of 2023?
Kenneth Lundström
Viruses (2024) Vol. 16, Iss. 2, pp. 203-203
Open Access | Times Cited: 9
Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
Guodong Liu, Wenguang Cao, Abdjeleel Salawudeen, et al.
Pathogens (2021) Vol. 10, Iss. 9, pp. 1092-1092
Open Access | Times Cited: 54
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 335-346
Open Access | Times Cited: 28
Immunobiology and immunotherapy of COVID-19
Kenneth Lundström
Progress in molecular biology and translational science (2025)
Closed Access
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
Yongping Yang, Wei Shi, Olubukola M. Abiona, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 73-73
Open Access | Times Cited: 34
Tumor Microenvironment‐Responsive Polymer‐Based RNA Delivery Systems for Cancer Treatment
Yahan Zhang, Ming Zhang, Haiqin Song, et al.
Small Methods (2024)
Closed Access | Times Cited: 3
SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge
Edward Sullivan, Po-Yu Sung, Weining Wu, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 914-914
Open Access | Times Cited: 17
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Development of virus‐like particles‐based vaccines against coronaviruses
Chean Yeah Yong, Winnie-Pui-Pui Liew, Hui Kian Ong, et al.
Biotechnology Progress (2022) Vol. 38, Iss. 6
Open Access | Times Cited: 15
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2
Philipp A. Ilinykh, Sivakumar Periasamy, Kai Huang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 9
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
Ernesto Garay, Diego Fontana, Javier Villarraza, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 11, pp. 3495-3508
Open Access | Times Cited: 3
An Overview of Recent Developments in the Application of Antigen Displaying Vaccine Platforms: Hints for Future SARS-CoV-2 VLP Vaccines
Doddy Irawan Setyo Utomo, Hamizah Suhaimi, Nor Azila Muhammad Azami, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1506-1506
Open Access | Times Cited: 3
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Molecular concepts for pandemic viruses : membrane fusion assays and targeting of reservoir cells
Samuel A. Theuerkauf
(2024)
Open Access
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
Grace Neilsen, Asha Maria Mathew, J.M. Castro, et al.
mBio (2024)
Open Access
Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
Justin Mark Lunderberg, Sanjucta Dutta, Ai‐ris Y. Collier, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Optimizing encephalomyocarditis virus VP1 protein assembly on pseudorabies virus envelope via US9 protein anchoring
Bincheng Ren, Hui Qin, Yubo Zhang, et al.
Virulence (2024) Vol. 16, Iss. 1
Open Access
Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses
Zijun Li, Jooeun Lee, Namki Cho, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21742-e21742
Open Access | Times Cited: 1
Repeated dosing improves oncolytic rhabdovirus therapy in mice via interactions with intravascular monocytes
Victor Naumenko, Jahanara Rajwani, Madison Turk, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Glycoproteins of Predicted Amphibian and Reptile Lyssaviruses Can Mediate Infection of Mammalian and Reptile Cells
Martina Oberhuber, Anika Schopf, Alexandru A. Hennrich, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1726-1726
Open Access | Times Cited: 2
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior protective humoral immune response to SARS-CoV-2
Adriano Taddeo, Inês Berenguer Veiga, Christelle Devisme, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1 - Next Page

Scroll to top